Published in BMC Health Serv Res on June 27, 2016
Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol (2012) 6.05
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol (2013) 5.40
Anal and cervical intraepithelial neoplasia: possible parallel. Lancet (1989) 2.52
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA (1999) 2.35
Carcinoma of the anal canal. N Engl J Med (2000) 2.22
Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst (2009) 2.17
Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study. Lancet Oncol (2007) 2.09
Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst (2001) 1.75
Anal intraepithelial neoplasia in women with genital intraepithelial neoplasia. Obstet Gynecol (2010) 1.65
Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ (2005) 1.47
Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.46
Cost-effectiveness analysis of recurrence score-guided treatment using a 21-gene assay in early breast cancer. Oncologist (2010) 1.42
Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: the Hawaii HPV Cohort Study. J Infect Dis (2010) 1.30
Abnormal outcomes following cervical cancer screening: event duration and health utility loss. Med Decis Making (2007) 1.28
Anal cancer: an overview. Oncologist (2007) 1.09
Colposcopic management of abnormal cervical cytology and histology. J Obstet Gynaecol Can (2012) 1.06
Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information. Value Health (2013) 1.05
Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer. Health Technol Assess (2010) 1.05
Cost-utility analysis of screening high-risk groups for anal cancer. J Public Health (Oxf) (2008) 1.02
Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm. Obstet Gynecol (2011) 0.99
HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues. BMC Cancer (2012) 0.95
Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening. Radiol Clin North Am (2010) 0.94
Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England. Gynecol Oncol (2003) 0.93
Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women. AIDS (2013) 0.93
Quality of life valuations of HPV-associated cancer health states by the general population. Sex Transm Infect (2012) 0.91
Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol (2010) 0.89
The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men. Sex Health (2012) 0.89
Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data. Am J Epidemiol (2013) 0.88
Natural history of cervical intraepithelial neoplasia: a meta-analysis. Acta Cytol (2005) 0.88
Incidence of ano-genital and head and neck malignancies in women with a previous diagnosis of cervical intraepithelial neoplasia. Gynecol Oncol (2014) 0.84
Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario. Gynecol Oncol (2009) 0.82
A cost-effectiveness analysis of anal cancer screening in HIV-positive women. J Low Genit Tract Dis (2012) 0.79
Anal dysplasia screening: an evidence-based analysis. Ont Health Technol Assess Ser (2007) 0.78